back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-02-20 Tx date 2019-02-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-32,600
-5,000 vol $6.52 each |
350,000 | |
| Filed 2019-02-20 Tx date 2019-02-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-33,680
-8,000 vol $4.21 each |
350,000 | |
| Filed 2019-02-20 Tx date 2019-02-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$33,680
+8,000 vol $4.21 each |
358,000 | |
| Filed 2019-02-20 Tx date 2019-02-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$32,599
+5,000 vol $6.52 each |
355,000 | |
| Filed 2019-01-13 Tx date 2019-01-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$33,680
+8,000 vol $4.21 each |
358,000 | |
| Filed 2019-01-13 Tx date 2019-01-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-33,680
-8,000 vol $4.21 each |
350,000 | |
| Filed 2019-01-13 Tx date 2019-01-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$50,000
+12,500 vol $4.00 each |
362,500 | |
| Filed 2019-01-13 Tx date 2019-01-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-50,000
-12,500 vol $4.00 each |
350,000 | |
| Filed 2019-01-13 Tx date 2019-01-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$65,199
+10,000 vol $6.52 each |
360,000 | |
| Filed 2019-01-13 Tx date 2019-01-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-65,200
-10,000 vol $6.52 each |
350,000 | |
| Filed 2019-01-03 Tx date 2018-12-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,456.40
-220 vol $6.62 each |
9,180 | |
| Filed 2018-02-06 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,304,000
+200,000 vol $6.52 each |
350,000 | |
| Filed 2017-12-15 Tx date 2017-12-15 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,172
+250 vol $4.69 each |
9,400 | |
| Filed 2017-10-25 Tx date 2017-10-24 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,952
+1,750 vol $5.69 each |
9,150 | |
| Filed 2017-07-06 Tx date 2017-06-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,400 | ||
| Filed 2017-06-30 Tx date 2017-06-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 |